CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 4 Open-market sale CEO sold 39,280 shares at $7.68 ($301,670)
- 4 Open-market sale Chief Innovation Officer sold 4,578 shares at $7.68 ($35,159)
- 4 Open-market sale Chief R&D Officer sold 6,881 shares at $7.68 ($52,846)
- 4 Open-market sale VP Operations sold 6,033 shares at $7.68 ($46,333)
- UPLOAD Other SEC-generated Letter
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale VP Operations sold 36,310 shares at $8.81 ($319,891)
- 4 Open-market sale Director sold 25,000 shares at $9.00 ($225,000)
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 4 Grant or award Chief Innovation Officer acquired 50,000 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
Page 12 of 69 · 1,369 filings